Recently, the analysis of the local CD8 and IDO1 expression profile has been found to serve as a helpful tool in predicting the prognosis of patients with locally advanced rectal cancer following neoadjuvant chemoradiation, with the subgroup of high total IDO1 and CD8 scores having the best prognosis by immunohistochemistry (54). The gene discussed is IDO1; the disease is rectal cancer.